News

Prediction: This AI Stock Will Soar After Feb. 25. Here's Why.

Key PointsNvidia is set to release its quarterly results on Feb. 25.The company is likely to crush analysts' expectations due to the robust demand for its AI chips.Nvidia's next-ge

Source  The Motley Fool1770873600
Why I'm Not Buying the Dip in Shopify Stock

Key PointsShares of Shopify are down 26% year to date.The e-commerce specialist's revenue rose 31% year over year during Q4.The company announced a $2 billion share repurchase prog

Source  The Motley Fool1770871860
Got $200? 1 Artificial Intelligence (AI) Stock to Buy and Hold for the Long Term.

Key PointsNvidia is preparing to launch its Rubin chip platform just as agentic AI is beginning to take off.The company acquired Groq, a proactive move for the future.Nvidia's stro

Source  The Motley Fool1770870000
Alphabet Stock: Is It Time to Buy the Dip?

Key PointsAlphabet expects capital expenditures to soar this year.The company's revenue growth rate is accelerating as AI is driving demand for its services.Alphabet generates abou

Source  The Motley Fool1770868860
Don't Tap Your IRA Early to Buy a Home in Today's Market

Key PointsEarly IRA withdrawals usually result in a 10% penalty.There's a limited exception for first-time homebuyers.Withdrawing IRA funds to buy a home is a move you might kick y

Source  The Motley Fool1770868380
2 No-Brainer Dividend Stocks to Buy Right Now

Key PointsSome stocks give you the perfect blend of high yield and promising growth potential, including these two REITs.Digital Realty Trust owns more than 300 data centers, and d

Source  The Motley Fool1770866400
The Motley Fool Interviews Droneshield CEO Oleg Vornik

In this podcast, Motley Fool co-founder and CEO Tom Gardner and Motley Fool data engineer Beegee Alop talk with Droneshield CEO Oleg Vornik about counter-drones, the civilian and m

Source  The Motley Fool1770864840
The Best Artificial Intelligence (AI) Stock to Buy Now

Key PointsMicrosoft owns a stake and partners closely with ChatGPT's creator, OpenAI.OpenAI's steep financial losses and competitive pressures have weighed on Microsoft.Despite som

Source  The Motley Fool1770864600
2 Red-Hot Growth Stocks to Buy in 2026

Key PointsThese tech stocks sell products and services that are key to the artificial intelligence boom.High demand has driven revenue growth at both companies.10 stocks we like be

Source  The Motley Fool1770863400
Here's Why I Still Wouldn't Touch Teladoc With a 10‑Foot Pole

Key PointsTeladoc has seen its share price tumble 98% from its 2021 peak. It has declining revenue and is not profitable. The company has lots of competition and lacks a moat to pr

Source  The Motley Fool1770863100
3 Dividend Stocks to Buy Right Now for Income and Upside

Key PointsRyman Hospitality offers investors a unique opportunity to earn income while investing in Music City.ONEOK’s diversified midstream scale supports strong cash-flow growth.

Source  The Motley Fool1770863100
Aprea Therapeutics Strengthens Global Patent Portfolio in DNA Damage Response (DDR) Cancer Therapeutics, Paving Way for Pipeline Growth

New patents granted in 2025 in Australia and Japan bolster global IP coverage for Aprea’s WEE1 and ATR programs. Core patent families are expected to provide exclusivity into 2045.Lead WEE1 inhibitor candidate APR-1051 is advancing in Phase 1 trials, with early clinical proof of concept demonstrated and multiple 2026 data readouts anticipatedBroad intellectual property protection and ongoing clinical progress position Aprea for long-term value creationDOYLESTOWN, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical-stage biopharmaceutical company developing innovative therapies that exploit cancer-specific vulnerabilities while minimizing damage to healthy cells, today announced significant recent expansions of its global intellectual property estate supporting its DDR-focused oncology pipeline.Aprea’s patent strategy is designed to secure durable global protection around its proprietary molecules, formulations, and therapeutic applications, to de-risk clinical development and maximize long-term commercial value.“Our intellectual property estate is a foundational asset for Aprea and a key component of our long-term strategy to create value and differentiate Aprea within the DDR therapeutics field,” said Oren Gilad, Ph.D., President and Chief Executive Officer of Aprea. “We are building a broad, defensible portfolio across both our WEE1 and ATR programs, strengthened by multiple new patents granted in 2025 in key global markets. This portfolio is designed to protect our core compounds, formulations, and methods of use. By securing broad protection globally into the 2040s, we are positioning our assets for further development, future commercialization and potential strategic transactions with the ultimate goal of bringing new treatment options to patients with difficult-to-treat cancers.”The Company’s lead WEE1 inhibitor, APR-1051, is currently being evaluated in the ACESOT-1051 Phase 1 clinical trial in advanced/metastatic solid tumors harboring certain cancer-associated gene alterations. Aprea’s WEE1 kinase inhibitor program is backed by an expanding global patent portfolio. The intellectual property estate includes one provisional U.S. patent application, two pending U.S. patent applications, one issued patent in Australia (issued in 2025) and 13 pending applications outside the United States. If granted, the core patents in the WEE1 family are expected to provide protection through 2042, excluding any additional regulatory exclusivities that may be available. The WEE1 portfolio is expected to protect key program assets, including new chemical entities (e.g., APR-1051), new pharmaceutical compositions comprising those entities, and methods of treating a range of oncology indications.The Company’s lead ATR inhibitor, ATRN-119, is currently being evaluated in the ABOYA-119 clinical trial as monotherapy in patients with advanced solid tumors. The Company’s ATR inhibitor program is protected by a robust patent estate. This includes four issued U.S. patents and one pending U.S. application, and one international application, as well as 21 granted patents, including one recently issued in Japan in 2025, and 15 pending applications in international jurisdictions. The ATR portfolios protects new chemical entities, new pharmaceutical compositions comprising those entities, and methods of treating a range of oncological indications. Existing issued patents are expected to remain in force through 2035–2037, excluding any additional regulatory exclusivity that may be available. The pending applications, if granted, could extend intellectual property protection into 2045.Aprea filed provisional applications in the U.S. in 2025 covering macrocyclic undisclosed DDR target inhibitors and methods of their preparation and use.About ApreaAprea is pioneering a new approach to treat cancer by exploiting vulnerabilities associated with cancer cell mutations. This approach was developed to kill tumors but to minimize the effect on normal, healthy cells, decreasing the risk of toxicity that is frequently associated with chemotherapy and other treatments. Aprea’s technology has potential applications across multiple cancer types, enabling it to target a range of tumors, including ovarian, endometrial, colorectal, prostate, and breast cancers.The company’s lead programs are APR-1051, an oral, small-molecule inhibitor of WEE1 kinase, and ATRN-119, a small molecule ATR inhibitor, both in clinical development for solid tumor indications. For more information, please visit the company website at www.aprea.com.Forward-Looking StatementCertain information contained in this press release includes “forward-looking statements”, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended related to our study analyses, clinical trials, regulatory submissions, and projected cash position. We may, in some cases use terms such as “future,” “predicts,” “believes,” “potential,” “continue,” “anticipates,” “estimates,” “expects,” “plans,” “intends,” “targeting,” “confidence,” “may,” “could,” “might,” “likely,” “will,” “should” or other words that convey uncertainty of the future events or outcomes to identify these forward-looking statements. Our forward-looking statements are based on current beliefs and expectations of our management team and on information currently available to management that involve risks, potential changes in circumstances, assumptions, and uncertainties. All statements contained in this press release other than statements of historical fact are forward-looking statements, including statements regarding our ability to develop, commercialize, and achieve market acceptance of our current and planned products and services, our research and development efforts, including timing considerations and other matters regarding our business strategies, use of capital, results of operations and financial position, and plans and objectives for future operations. Any or all of the forward-looking statements may turn out to be wrong or be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. These forward-looking statements are subject to risks and uncertainties including, without limitation, the risk that the proposed private placement and the transactions described herein may not be completed in a timely manner or at all, the failure to realize the anticipated benefits of the private placement and related transactions, market and other conditions, as well as other factors described under “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in the documents we file with the U.S. Securities and Exchange Commission. For all these reasons, actual results and developments could be materially different from those expressed in or implied by our forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which are made only as of the date of this press release. We undertake no obligation to update such forward-looking statements for any reason, except as required by law.Investor Contact:Mike MoyerLifeSci Advisorsmmoyer@lifesciadvisors.com12/02/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

Source  EQS1770862463
McGraw Hill (MH) Q3 2026 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; m

Source  The Motley Fool1770862086
Sands China, Alipay and Macau Pass Deepen Partnership to Drive Digital Upgrade

Leveraging innovative payment experience to attract visitors to MacaoMacao, Feb. 12, 2026 – During Chinese New Year, Sands China Ltd., Alipay, and Macau Pass, are further deepening their partnership to enhance the smart tourism experience, while supporting the digital upgrade of Macao’s tourism sector and local merchants’ operations. Together, they have launched the ‘Tap for Luck, Tap for Golden Surprises’ Chinese New Year campaign. Built on Alipay Tap! interactive technology, the campaign integrates tap-to-check-in interactions and other engaging features to attract more tourists to Macao, offering them a seamless, one-stop smart spending experience.Sands China has fully implemented Alipay Tap! across its resorts, offering a seamless tap-to-pay experience in a broad range of scenarios, fromretail and dining to beauty, fashion and souvenir shops. This upgrade not only significantly simplifies the payment process for consumers but also greatly enhances operational efficiency for businesses. Sands China has also introduced the handheld Alipay Tap! devices, enabling staff to process payments anywhere in the store. This improves service efficiency and customer experience, particularly in high-end settings.Grant Chum, Chief Executive Officer and Executive Director of Sands China Ltd., said, “Sands China is honoured to be the first operator in Macao to roll out the Alipay Tap! digital experience, marking a significant step forward in our collaboration with Alipay. By integrating the strengths of the tourism and leisure industry with digital payment platforms, this partnership not only creates a smarter and more convenient consumption and payment experience for guests but also unlocks new digital business and marketing opportunities, injecting fresh vitality into the development of Macao as a smart city and the high-quality growth of its tourism industry.”Han Xinyi, CEO and Executive Director of Ant Group, stated, “As a vital hub for digital connectivity in the Greater Bay Area, Macao offers an ideal environment for digital technology innovation and deployment. By extending Alipay Tap! service from payments into membership engagement, interactive experiences, and handheld-checkout scenarios, we aim to keep improving the convenience of payments and consumption, and to foster deeper integration and innovation across the Greater Bay Area’s digital ecosystem.”Sun Hao, Macau Pass Chairman and CEO, said, “As a leader in Macao’s local digital services, Macau Pass has always been committed to using technology to drive industry development and improve people’s livelihoods. This collaboration is another important step following our push topromote Alipay Tap! payment service, as we deepen scenario-based applications and expand our service ecosystem.We will continue to work with partners to deliver innovative experiences and supportMacao’s smart-city development.”Launched over a year ago in Macao, the Alipay Tap! service has evolved from a convenient payment tool into a comprehensive digital ecosystem, nowenabling interactive Alipay Tap! check-ins, ‘Pay-to-Join’ membership and handheld-checkout across multiple service scenarios. Its coverage and depth of services continue to grow, not only enhancing the spending experience for visitors to Macao, but also digitally integrating traditionally fragmented functions such as cashiering, membership registration, user operations and offline events. The solution simplifies checkout processes, lowers operating costs, improves member retention and engagement, and more closely aligns offline consumer scenarios with user demand.Photo:Alipay's ‘Tap for Luck, Tap for Golden Surprises’ Chinese New Year campaign available at Sands China's resorts.About Sands China Ltd. Sands China Ltd. (Sands China or the Company) is incorporated in the Cayman Islands with limited liability and is listed on The Stock Exchange of Hong Kong Limited (HKEx: 1928).Sands China is the largest operator of integrated resorts in Macao. The Company’s integrated resorts on the Cotai Strip comprise The Venetian®Macao, The Plaza®Macao, The Parisian® Macao and The Londoner®Macao. The Company also owns and operates Sands®Macao on the Macao peninsula. The Company’s portfolio features a diversified mix of leisure and business attractions and transportation operations, including large meeting and convention facilities; a wide range of restaurants; shopping malls; world-class entertainment at The Venetian Arena, The Londoner Arena, The Venetian Theatre, The Parisian Theatre, the Londoner Theatre and the Sands Theatre; and a high-speed Cotai Water Jet ferry service between Hong Kong and Macao. The Company’s Cotai Strip portfolio has the goal of contributing to Macao’s transformation into a world centre of tourism and leisure. Sands China is a subsidiary of global resort developerLas Vegas Sands Corp.(NYSE: LVS).For more information, please visit www.sandschina.com.About MACAU Pass Group Holdings Limited Macau Pass Group Holdings Limited is a diversified group company engaged in various fields, including financial technology, payment services, local lifestyle services, tourism services, and cultural performances. Macau Pass Group is committed to continuous innovation and development, aiming to serve as a bridge connecting Macao with the world and promoting the common prosperity of the regional economy and culture. One of subsidiaries of Macau Pass Group, Macau Pass S.A, has issued the first contactless smart electronic payment card in Macao, the mCard, with a cumulative issuance exceeding 5.5 million cards, meeting the payment needs of all residents and tourists at nearly 30,000 payment points in Macao. Its sub-brand, MPay, registered users accounting for over 90% of the total local population and is also the local app with the highest daily active users in Macao. Macau Pass Group also operates a highly recognized and utilized membership points system in Macao, mCoin, which has partnered with various cultural, sports, and exhibition events. mPass integrates a variety of one-stop local services, providing consumers visiting Macao with a diverse range of products and services, including dining, cultural entertainment, transportation, shopping, and travel vacations, taking consumers to explore the vibrant life in Macao.Media contacts:Public Relations, Sands China Ltd.Dan LiTel: +853 8118 2056Email: dan.li@sands.com.moPosy KuokTel: +853 8118 2010Email: posk.kuok@sands.com.mo Public Relations, Macau Pass Group Holdings Ltd.Zoe FanTel: ++86 18811719921Email: fanpei.fp@alibaba-inc.com12/02/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

Source  EQS1770861642
Neurocrine (NBIX) Q4 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; m

Source  The Motley Fool1770861551
McDonald's (MCD) Q4 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; m

Source  The Motley Fool1770861536
Cisco (CSCO) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; m

Source  The Motley Fool1770861314
Why Zillow Stock Dropped Today

Key PointsZillow's rentals and mortgages businesses are growing quickly.Yet a projected earnings shortfall drove many investors to sell.10 stocks we like better than Zillow Group ›

Source  The Motley Fool1770861186
Viking (VKTX) Q4 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; m

Source  The Motley Fool1770861130
6.4 Million Medicare Recipients Face New Hurdles in Getting Care

Key PointsTraditional Medicare typically does not require preapproval for services.A new pilot program launched in January changes the rules.More procedures must be preapproved, in

Source  The Motley Fool1770861000
Porch Group PRCH Q4 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; m

Source  The Motley Fool1770860608
Is Iren Stock Your Ticket to Becoming a Millionaire?

Key PointsIren didn't announce a new deal in its earnings but hinted at multiple advanced negotiations leading up to the energization of Sweetwater 1.Tech companies need AI data ce

Source  The Motley Fool1770860100
I Predicted That ExxonMobil Would Join the $1 Trillion Club by 2030, But the Stock Is Already Up 24% in 2026. Is the High-Yield Dividend Stock Still a Buy Now?

Key PointsExxonMobil is delivering solid results despite relatively low oil prices.It's benefiting from lower production costs, a more efficient upstream portfolio, and higher refi

Source  The Motley Fool1770859500
Kornit Digital (KRNT) Q4 2025 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; m

Source  The Motley Fool1770859332
Q2 Holdings (QTWO) Q4 2025 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; m

Source  The Motley Fool1770858219
1 Top Dividend Stock to Buy and Hold for 10 Years

Key PointsMcDonald's value menu is resonating with customers.The fast-food giant's loyalty program is growing rapidly.The company's comparable sales growth rate accelerated signifi

Source  The Motley Fool1770858109
Ascendis Pharma (ASND) Q4 2025 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; m

Source  The Motley Fool1770857419
FSTA vs. RSPS: Which Consumer Staples ETF Is the Better Buy Right Now?

Key PointsFSTA charges a much lower expense ratio and manages over five times the assets of RSPS.RSPS delivered a higher one-year return, but FSTA has shown a smaller five-year dra

Source  The Motley Fool1770857278
The "Magnificent Seven" Plan to Spend $680 Billion Largely on Artificial Intelligence Capex: Is Now the Time to Pile Into the Group?

Key PointsDespite market concerns, the "Magnificent Seven" are moving full steam ahead with AI-related capital expenditures.Many of the large tech companies view AI as an arms race

Source  The Motley Fool1770856560
Redwire: A Promising Player in the Space Industry or a Risky Investment?

Explore the exciting world of Redwire (NYSE: RDW) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights

Source  The Motley Fool1770855600
goTop
quote